Navigation Links
Amicus Therapeutics Announces Third Quarter 2007 Financial Results
Date:10/31/2007

tion expense recorded

in accordance with SFAS No. 123R. We believe that excluding the

impact of expensing stock options better reflects the recurring

economic characteristics of our business.

(3) Other items - Non-GAAP net loss and diluted net loss per common

share exclude other unusual or non-recurring items that are evaluated

on an individual basis. Our evaluation of whether to exclude an item

for purposes of determining our non-GAAP financial measures considers

both the quantitative and qualitative aspects of the item, including,

among other things (i) its size and nature, (ii) whether or not it

relates to our ongoing business operations, and (iii) whether or not

we expect it to occur as part of our normal business on a regular

basis. Items excluded for purposes of determining non-GAAP net loss

and diluted net loss per common share include deemed dividends,

preferred stock accretion, and changes in the fair value of warrant

liability.

About Amicus Therapeutics

Amicus Therapeutics is a biopharmaceutical company developing novel, oral therapeutics known as pharmacological chaperones for the treatment of a range of human genetic diseases. Pharmacological chaperone technology involves the use of small molecules that selectively bind to and stabilize proteins in cells, leading to improved protein folding and trafficking, and increased activity. Amicus is initially targeting lysosomal storage disorders, which are severe, chronic genetic diseases with unmet medical needs. Amicus has two product candidates in Phase II clinical trials, Amigal(TM) for the treatment of Fabry disease and Plicera(TM) for the treatment of Gaucher disease. The Company is also conducting Phase I clinical trials of AT2220 for the treatment of Pompe disease.

Forward-Looking Statements

Amicus cautions you that state
'/>"/>

SOURCE Amicus Therapeutics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Canadian firm buys Proventiv Therapeutics, makes ex-Bone Care exec CEO
2. Speaker announces business members of IT Task Force
3. Doyle announces technology tax credits for Berbee
4. Doyle announces new energy, global warming policies
5. Doyle announces $80M renewable energy strategy
6. GE announces first installation of Discovery VCT
7. UWM announces winners of RGI awards
8. Third Wave announces two senior management appointments
9. Mirus announces new method for making antibodies
10. Merge announces sofware updates, upcoming acquisition
11. Small Tree announces ethernet solution for Apple Xserv G5
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... August 21, 2014 DNA vaccine pioneer ... in its development of JRC-LAMP-vax, an innovative and safe ... Phase IC studies began this month in Hawaii, moving ... fever. , The Japanese red cedar releases pollen that ... Japan. Mountain Cedar pollen wreaks similar havoc in Colorado, ...
(Date:8/21/2014)... August 21, 2014 His Majesty Willem-Alexander, ... , The Court of His Majesty Willem-Alexander, King of ... the Grand Opening of POET-DSM Advanced Biofuels’ Project LIBERTY ... 3. , The King will take part in the ... scheduled for 11 a.m.-12:20 p.m. and tour the plant. ...
(Date:8/21/2014)... OTC Markets Group Inc. ... company, on its approval to list on The ... the best marketplace for established U.S. and global ... Logo - http://photos.prnewswire.com/prnh/20110118/MM31963LOGO "We ... its growth strategy and achievement of this important ...
(Date:8/21/2014)... 2014 Gallus BioPharmaceuticals , ... and manufacturing organization (CMO) announced today that it ... oncology company focused on the development of innovative ... the anti-prostate specific membrane antigen (PSMA) monoclonal antibody ... Under the agreement the antibody will be produced ...
Breaking Biology Technology:Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 2Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 3Relief for Allergy Sufferers Finally in Sight: Immunomic Therapeutics Closes in on Treatment for Hay Fever in Japan, U.S. 4His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 2His Majesty Willem-Alexander, King of the Netherlands, to Attend Project LIBERTY opening 3OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 2Gallus Enters Agreement with Progenics Pharmaceuticals, Inc. for Manufacture of Anti-PSMA Monoclonal Antibody 3
... you played was Pac-Man, you might have missed the advances ... and leaders. , ,Three University of Wisconsin-Madison professors, among the ... games over traditional teaching tools Thursday evening. , ... in Madison by Accelerate Madison and WTN ...
... considers wireless bids ,The City of Madison received bids ... InSite Wireless to build wireless hotspots around the ... was Monday. The winning vendor will pay the city, county ... be able to charge access fees. Certain local sites could ...
... company that makes optical tests capable of quickly finding ... of its $5 million investment round. , ,OpGen, a ... sells its testing services to a variety of clients. ... service and new developments such as packaged instruments that ...
Cached Biology Technology:Games that make leaders: top researchers on the rise of play in business and education 2Games that make leaders: top researchers on the rise of play in business and education 3Games that make leaders: top researchers on the rise of play in business and education 4Tech Digest: Madison wireless, angels, Third Wave, Esker, Research Park 2OpGen completes $5 million investment round 2
(Date:8/21/2014)... AWI geologist Juliane Mller the Fram Strait is a key ... of this passage between Greenland and Svalbard warm Atlantic water ... the west side cold Arctic water masses and sea ice ... Atlantic. A considerable portion of the Atlantic water cools here ... layers. The circulation of the water caused in this manner ...
(Date:8/21/2014)... LAWRENCE A study recently published in the journal ... Kansas shows a new role for the protein adenomatous ... second-leading cause of cancer-related deaths in the U.S. , ... of Molecular Biosciences and co-leader of the Cancer Biology ... better part of her career trying to understand the ...
(Date:8/21/2014)... successfully replicated one of the crucial steps in photosynthesis, ... which could manufacture hydrogen as a fuel. , "Water ... exciting prospect to use them to create hydrogen, and ... from the ARC Centre of Excellence for Translational Photosynthesis ... offers potential as a zero-carbon replacement for petroleum products, ...
Breaking Biology News(10 mins):Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Water and sunlight the formula for sustainable fuel 2
... UPTON, NY Hydrogen gas offers one of the ... But traditional methods of producing pure hydrogen face significant ... harmful carbon dioxide into the atmosphere or requiring rare ... scientists at the U.S. Department of Energy,s (DOE) Brookhaven ...
... press release is available in German . ... more,autonomy and far more freedom of discretion. Today, the ... a result of which KIT will be principal of ... future. In,addition, KIT will have the right to make ...
... rats demonstrates that the anti-epilepsy drug phenobarbital stunts neuronal ... first-line drug to treat epilepsy in human newborns. ... May 11, researchers at Georgetown University Medical Center (GUMC) ... pups about a week old changed the way the ...
Cached Biology News:Low-cost nanosheet catalyst discovered to split hydrogen from water 2Low-cost nanosheet catalyst discovered to split hydrogen from water 3Low-cost nanosheet catalyst discovered to split hydrogen from water 4More freedom of discretion for KIT 2Study raises questions about use of anti-epilepsy drugs in newborns 2Study raises questions about use of anti-epilepsy drugs in newborns 3
... of samples may be carried out using this ... minimum operator attention. System control and data ... CE 4900. The elegant, powerful and very ... and Windows 98 and 2000., The supplied automatic ...
... ideal for routine binary separations. Excellent detection ... 4201 UV-Visible variable wavelength detector. Ultra-fine control ... two highly accurate and precise, high pressure ... pumps., Chromatograms may be plotted on a printer ...
...
... Human Raji cells were cultured in RPMI 1640 ... the log phase of growth. In order ... cells were fixed in acetone-methanol. The cells ... coated slide, with each wells surface specifically treated ...
Biology Products: